Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies

Código QR

Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies

Hugo Quiroz-Mercado, 1 Ehud Ivri, 2 Roberto Gonzalez-Salinas, 1 Iraklis C Kourtis, 2 Joseph Gilbert, 2 José Francisco Pérez-Vázquez, 1 Mark Blumenkranz, 2 Jesús Jiménez-Román, 1 George Marcellino 2 1Association to Prevent Blindness,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Quiroz-Mercado H, Ivri E, Gonzalez-Salinas R, Kourtis IC, Gilbert J, Pérez-Vázquez JF, Blumenkranz M, Jiménez-Román J, Marcellino G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	mydriasis phenylephrine tropicamide glaucoma intraocular pressure latanoprost topical ocular drug delivery safety Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/ece07883a85a439abce65e97e1a190da
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study
por: Okumichi H, et al.
Publicado: (2017)

Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan® and Arulatan®) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
por: Brant Fernandes RA, et al.
Publicado: (2019)

Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery
por: Guell J, et al.
Publicado: (2019)

Comparison of the frequency of use of a pupil expansion device with and without an intracameral phenylephrine and ketorolac injection 1%/0.3% at the time of routine cataract surgery
por: Bucci Jr FA, et al.
Publicado: (2017)

SIMULTANEOUS DETERMINATION OF PHENYLEPHRINE HYDROCHLORIDE AND TROPICAMIDE IN OPHTHALMIC DOSAGE FORM WITH THREE RAPID DERIVATIVE SPECTROPHOTOMETRIC METHODS
por: SARDANA,SWATI, et al.
Publicado: (2010)

Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study
por: Takemoto D, et al.
Publicado: (2017)

Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
por: Economou MA, et al.
Publicado: (2018)

The effects of repeated Ozurdex injections on ocular hypertension
por: Bahadorani S, et al.
Publicado: (2018)

A new device to noninvasively estimate the intraocular pressure produced during ocular compression
por: Korenfeld MS, et al.
Publicado: (2016)

Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
por: Martin P, et al.
Publicado: (2020)

Efficacy of Nepafenac versus Flurbiprofen in Maintaining Intraoperative Mydriasis During Phacoemulsification: A Comparative Study
por: Shrivastava AK, et al.
Publicado: (2021)

Review of external ocular compression: clinical applications of the ocular pressure estimator
por: Korenfeld MS, et al.
Publicado: (2016)

Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma
por: Siddiqui M, et al.
Publicado: (2019)

Ocular hypertension and hypotony as determinates of outcomes in uveitis
por: Aman R, et al.
Publicado: (2015)

Improved Efficacy of Topical Latanoprost 0.005% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism
por: Radcliffe N, et al.
Publicado: (2020)

Incidence and outcomes of ocular hypertension from rhegmatogenous retinal detachment surgery in the acute postoperative setting
por: Bromeo AJ, et al.
Publicado: (2019)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
por: Beck DER, et al.
Publicado: (2017)

A Comparative Study Between the Goldmann Applanation Tonometer and the Non-Contact Air-Puff Tonometer (Huvitz HNT 7000) in Normal Eyes
por: Stock RA, et al.
Publicado: (2021)

Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost
por: Erb C, et al.
Publicado: (2021)

Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
por: Ikeda Y, et al.
Publicado: (2016)

The role of corneal hysteresis during the evaluation of patients with possible normal-tension glaucoma
por: Chen M, et al.
Publicado: (2018)

Comparison of successful outcome predictors for MicroPulse® laser trabeculoplasty and selective laser trabeculoplasty at 6 months
por: Hirabayashi MT, et al.
Publicado: (2019)

Glaucoma therapy: preservative-free for all?
por: Thygesen J
Publicado: (2018)

Topical Medication Therapy for Glaucoma and Ocular Hypertension
por: Tao Wang, et al.
Publicado: (2021)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
por: Wang N, et al.
Publicado: (2020)

Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost
por: Halder A, et al.
Publicado: (2020)

Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis
por: Iyer JV, et al.
Publicado: (2017)

Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution
por: Lee D, et al.
Publicado: (2017)

Comparative Study between Topical Latanoprost versus Topical 5- Fluorouracil after Dermabrasion for Treatment of Non-Segmental Stable Vitiligo
por: Rehab Abd El Razek, et al.
Publicado: (2021)

Susceptibilidad de las Mucosas Oculares al SARS COV-2: Bioseguridad Sanitaria
por: Rodríguez-Bustos,Héctor, et al.
Publicado: (2021)

Effect of Mydriasis-Caused Intraocular Pressure Changes on Corneal Biomechanical Metrics
por: Yufeng Ye, et al.
Publicado: (2021)

The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
por: Wannamaker KW, et al.
Publicado: (2019)

Is Saffron Able to Prevent the Dysregulation of Retinal Cytokines Induced by Ocular Hypertension in Mice?
por: José A. Fernández-Albarral, et al.
Publicado: (2021)

Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
por: Pasquale LR, et al.
Publicado: (2018)

A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
por: Maneesha Peter, et al.
Publicado: (2020)

Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
por: Shen J, et al.
Publicado: (2017)

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
por: Lerner SF, et al.
Publicado: (2019)

Ocular angiostrongyliasis in Thailand: a retrospective analysis over two decades
por: Sinawat S, et al.
Publicado: (2019)

Incidence of and risk factors for secondary ocular hypertension in moderate to severe infectious ulcerative keratitis
por: Sakiyalak D, et al.
Publicado: (2018)

Blood pressure, ocular perfusion pressure and open-angle glaucoma in patients with systemic hypertension
por: Cantor E, et al.
Publicado: (2018)